Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00212160 · ClinicalTrials.gov registry record · NA
The Role of the Omentum in the Treatment of Morbid Obesity
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT00212160 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 66 participants.
The verdict
NCT00212160, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this research is to determine some of the reasons that blood sugar and insulin levels improve after bariatric surgery but before weight loss begins, as well as why people respond differently to weight loss surgery. It will also examine whether removing the fat around the stomach and large intestine (the omentum) will improve weight loss. Finally, it will see why there are differences between Whites and African Americans who have weight loss surgery.
Interventions
- PROCEDURE omentectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2005-01 |
| Est. Completion | 2011-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00212160
The ClinicalTrials.gov registry entry for NCT00212160 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which omentectomy is the first listed.
NCT00212160 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00212160 about?
NCT00212160 is a clinical study titled "The Role of the Omentum in the Treatment of Morbid Obesity". The purpose of this research is to determine some of the reasons that blood sugar and insulin levels improve after bariatric surgery but before weight loss begins, as well as why people respond differently to weight loss surgery. It will also examine whether removing the fat around the stomach and l...
What is the current status of trial NCT00212160?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2005-01. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00212160?
The interventions under investigation include: omentectomy (PROCEDURE).
Who is sponsoring clinical trial NCT00212160?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.